Each morning for eight weeks, Douley Olivier dragged himself out of bed at 5 a.m. to drop his girlfriend at work so he could drive her car across Dorchester to train as a lab technician in the ...

On the pages of the calendar, it wasn’t too long ago that the thought of synthetic messenger RNA (mRNA) vaccines seemed quite imaginary to students in the Biotechnology Program at Thomas Jefferson ...

“What is happening with chemistry in America?” queries Matthew D. Hall, a biology group leader at the US National Center for Advancing Translational Sciences (NCATS) in a Twitter post July 8. “We’re ...

On Chicago’s South Side, the site of the defunct Michael Reese Hospital is poised to evolve into the $3.8B Bronzeville Lakefront development, a project backers say will reinvigorate the region with ...

Are ADCs having a moment? Is CAR-T safe? And who’s to blame for failed trials? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. We discuss why AbbVie is spending $10 ...

More and more people, especially early career workers, want jobs fighting climate change. But when we think about climate work, we tend to imagine only a small number of activities, like integrating ...